XML 27 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Nov. 30, 2021
Nov. 30, 2020
Nov. 30, 2019
Cash flows provided by (used in) operating activities      
Loss from continuing operations for the year $ (12,779,371) $ (4,028,297) $ (5,672,361)
Operating expenses of discontinued operations 79,179 56,760
Items not affecting cash:      
Accretion expense 10,067 51,520 158,736
Accrued interest income (41,382) 96,399 (45,653)
Accrued interest expense 3,323 (46,153) 122,005
Accrued income taxes 5,206
Allowance for credit loss 101,085 142,159 109,437
Amortization - intangibles 136,992 75,397 75,397
Amortization - licenses 213,015 444,519 1,367,318
Amortization – right-of-use asset 10,718
Depreciation 32,476 27,836 1,175
Change in value of derivatives (210,436) (918,102) 338,719
Commitment to issue shares 25,000
Deferred income tax recovery (12,971) (122,201)
Impairment of intangible assets 4,214,445
Interest on lease liability 771
(Gain) loss on settlement of debt (38,258) (30,473) 74,168
Loss on disposal of equipment 45,466
Loss on disposal of investment 3,438,560
Share of (profit) loss on equity investment (147,049)
Share-based compensation 1,674,322 1,447,476 891,099
Shares issued for services 46,948 184,910 55,514
Unrealized foreign exchange 1,782 (26) (42,450)
Unrealized gains on equity instruments (1,139,133) (1,785,885) (721,384)
Write-off of license fees 492,751 250,581 542,290
Write-off of old accounts payable 199,545
Changes in non-cash working capital:      
Receivables (406,612) (140,222) (490,370)
Inventory 105
Prepaids 364,623 (183,927) (263,405)
Accounts payable and accrued liabilities 130,430 (640,756) 626,675
Deferred revenue (67,441)
 Cash flows from (used in) operating activities (3,572,974) (4,973,865) (3,060,580)
Cash flows provided by (used in) investing activities      
Cash acquired on purchase of IndieFlix 21,076
Cash disposed on sale of Majesco (79,590)
Acquisition of equipment (43,303)
Investment in content (40,984)
Investment in intangibles (3,340,426)
Proceeds on disposal of equity instruments 666,683
Loan receivable received 64,196 8,558
Interest received on loans 9,307 5,007
Advances for acquisitions (2,182,694)
Restricted cash received 510,879 431,917
Purchase of restricted deposit certificates (53,937) (4,700) (506,179)
Investing expenses of discontinued operations (100,000)
 Cash flows from (used in) investing activities (1,589,856) (2,883,637) (160,697)
Cash flows provided by (used in) financing activities      
Loan proceeds 1,143 612,215
Loan repayments (585,388) (104,197)
Loan repayments to related parties (129,463)
Long-term debt proceeds 40,059
Long-term debt repayments (37,343)
Interest paid on loans (2,716) (17,446)
Convertible debentures received 2,660,000
Lease payments (10,298)
Shares and warrants issued for cash 6,915,230 4,000,002
Share issuance costs (573,351) (548,481)
Commitment to issue shares 440,501 78,750
Warrants exercised and issued for cash 2,613,993 1,472,000 277,010
Options exercised and issued for cash 19,000 136,438
 Cash flows from (used in) financing activities 8,924,515 4,956,274 3,376,869
Effect of foreign exchange on cash 27 (7,045) 43,143
Change in cash during the year 3,761,712 (2,908,273) 198,735
Cash, beginning of year 543,749 3,452,022 3,253,287
Cash, end of year 4,305,461 543,749 3,452,022
Supplemental cash-flow disclosure      
Interest received 12,067 5,007
Interest paid $ 2,569 $ 304,924 $ 17,446